Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bone Marrow Diseases × Busulfan × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 54 Leukemia 48 Myelodysplastic Syndromes 46 Lymphoma 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Lymphoma, Non-Hodgkin 39 Hodgkin Disease 34 Multiple Myeloma 32 Leukemia, Lymphocytic, Chronic, B-Cell 29 Lymphoma, Mantle-Cell 23 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 23 Neoplasms, Plasma Cell 21 Congenital Abnormalities 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Burkitt Lymphoma 20 Lymphoma, Large-Cell, Immunoblastic 19 Leukemia, Myeloid, Accelerated Phase 19 Blast Crisis 19 Myeloproliferative Disorders 18 Leukemia, Myeloid, Chronic-Phase 18 Primary Myelofibrosis 16 Hematologic Neoplasms 14 Graft vs Host Disease 13 Lymphoma, T-Cell, Cutaneous 12 Dendritic Cell Sarcoma, Interdigitating 12 Myelodysplastic-Myeloproliferative Diseases 11 Anemia, Refractory, with Excess of Blasts 11

Interventions

ponatinib 4 ruxolitinib 3 nilotinib 3 Imatinib Mesylate 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 sonidegib 1 simtuzumab 1 pembrolizumab 1 ibrutinib 1 bosutinib 1 Zoledronic Acid 1 Denosumab 1 BID protein, human 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡